Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Market status
Market status
Under Development
Products 101 to 110 of 119
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Salt Tolerant Tomatoes
by
Salt Farm Texel
Biotech components:
Plant
Business models:
B2B
Country of production:
Netherlands
Country of distribution:
Netherlands
+
Pakistan
+
Bangladesh
+
Ghana
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:52 (6 years ago)
Known funding amount:
500,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Self-Limiting Diamondback Moth
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (5 years ago)
Date last modified:
2019/09/12 14:53 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Animal
+
Food
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Self-Limiting Medfly
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (5 years ago)
Date last modified:
2019/09/12 14:53 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Animal
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
SER150DN
by
Serodus
+
Evolva
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/09 16:29 (5 years ago)
Known funding amount:
102,000,000 NOK
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
+
More information needed
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Sitagliptin
by
Codexis
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
37,000,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
CDXS
(NASDAQ)
Value chain stage:
Input
Sleeping Beauty
by
Ziophram
Biotech components:
Virus
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
182,600,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medicine
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
ZIOP
(NASDAQ)
Value chain stage:
Finished Product
SNS-301 (noninfectious lambda bacteriophage viruses)
by
Sensei Biotherapeutics
Biotech components:
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:40 (3 years ago)
Date last modified:
2020/12/18 14:40 (3 years ago)
Known funding amount:
28,500,000 USD
Funding types:
Private Funding
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Solein
by
Solar Foods
Biotech components:
Bacteria
Business models:
B2B
+
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:34 (3 years ago)
Date last modified:
2020/12/18 14:34 (3 years ago)
Known funding amount:
18,500,000
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Feed
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
+
Platform
Vaxonella
by
Prokarium
Biotech components:
Bacteria
Business models:
B2C
Country of production:
UK
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 16:12 (5 years ago)
Known funding amount:
12,600,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
On the market
+
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Spider Pillar
by
Kraig Biocraft Laboratories
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Vietnam
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
5,000,000 USD
Funding types:
Government
+
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
Web search
Trading symbol:
KBLB
(OTCMKTS)
Value chain stage:
Input
1
…
3
4
5
6
7
8
9
10
11
12
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
